Norbert G Riedel insider trades

Open-market stock purchases and sales by Norbert G Riedel, Director at Jazz Pharmaceuticals plc, from SEC Form 4 filings since Jan 20, 2010.

Recent trades

DateStockTradeValue
Aug 31, 2026JAZZ Jazz Pharmaceuticals plcSold (not open market)$3.4K
Aug 31, 2026JAZZ Jazz Pharmaceuticals plcSold (not open market)$408K
Aug 5, 2026JAZZ Jazz Pharmaceuticals plcBought (not open market)—
Apr 21, 2026ETON Eton Pharmaceuticals, IncBought (not open market)—
Apr 21, 2026ETON Eton Pharmaceuticals, IncBought (not open market)—
Feb 27, 2026JAZZ Jazz Pharmaceuticals plcSold$656K
Feb 27, 2026JAZZ Jazz Pharmaceuticals plcBought (not open market)—
Feb 3, 2026ETON Eton Pharmaceuticals, IncBought (not open market)—
Jan 12, 2026ETON Eton Pharmaceuticals, IncBought (not open market)—
Jan 12, 2026ETON Eton Pharmaceuticals, IncBought (not open market)—

Companies traded

  • JAZZ Jazz Pharmaceuticals plc: 17 sales, last Aug 31, 2026
  • ETON Eton Pharmaceuticals, Inc: 1 buy, last Apr 21, 2026
  • CERE Cerevel Therapeutics Holdings, Inc: other filings, last Aug 1, 2024
  • APTX Aptinyx Inc: 3 buys, last Jan 3, 2023
  • ARIA Ariad Pharmaceuticals Inc: other filings, last Feb 16, 2017
  • BAX Baxter International Inc: 2 sales, last Jan 16, 2013

Get free alerts when Norbert G Riedel files a new trade →